Hsbc Holdings PLC lowered its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 122,010 shares of the medical technology company's stock after selling 9,315 shares during the quarter. Hsbc Holdings PLC owned about 0.26% of Teleflex worth $21,724,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in shares of Teleflex in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC grew its position in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after acquiring an additional 125 shares during the period. IFP Advisors Inc increased its stake in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after acquiring an additional 217 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Finally, R Squared Ltd purchased a new position in shares of Teleflex during the 4th quarter worth $64,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
TFX has been the topic of several research analyst reports. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Wells Fargo & Company decreased their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Morgan Stanley dropped their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. StockNews.com cut Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Finally, Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and dropped their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $169.63.
Read Our Latest Stock Analysis on TFX
Teleflex Stock Down 0.4 %
Shares of NYSE TFX opened at $135.08 on Friday. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The stock has a market cap of $6.26 billion, a P/E ratio of 26.85, a PEG ratio of 1.73 and a beta of 1.19. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business's fifty day simple moving average is $140.16 and its 200-day simple moving average is $173.91.
Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. As a group, equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's dividend payout ratio is presently 95.77%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.